President Trump was administered dexamethasone therapy for COVID-19 treatment, and had two episodes of low oxygen saturation levels that required supplemental oxygen, said doctors at Walter Reed Medical Center at a press conference on Sunday.
“In response to transient low oxygen levels, we did initiate dexamethasone therapy [and] our plan is to continue that for the time being,” said Brian Garibaldi, MD, of Johns Hopkins University. He also confirmed the president received his second dose of remdesivir.
White House physician Sean Conley, DO, said the team “debated on whether or not to start” dexamethasone, but added, “the potential benefits probably outweighed any risk at this time.”
Dexamethasone is a low-cost steroid that has shown the most benefit for the sickest patients with COVID-19. According to the U.K.’s RECOVERY trial, incidence of mortality was significantly lower for patients receiving mechanical ventilation, and those receiving supplemental oxygen without mechanical ventilation, but there